17 October 2018
Time: 3:00 - 4:00pm
Speaker: Dr Sarah Stabenfeldt
Venue: PP1 People's Palace, Mile End Campus, Queen Mary University of London
Over 1.7 million persons sustain a traumatic brain injury (TBI) in the U.S. alone. TBI is initiated by a mechanical injury and leads to a biochemical injury that is largely responsible for long-term functional and cognitive deficits. However, there are limited clinical therapeutic treatment options currently available for TBI patients where notably none address the underlying pathology and only alleviate secondary symptoms (i.e. edema, intracranial pressure, etc). This talk will focus on bioengineering approaches our lab is exploring to promote regeneration/repair after TBI.